查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
專業仿製藥全球市場規模研究,按類型（注射,口服,其他）,應用（腫瘤學,炎症性疾病,丙型肝炎,多發性硬化症,其他）,用途（零售,醫院,其他）2022-2028區域預測
市場調查報告書
商品編碼
1119099

專業仿製藥全球市場規模研究,按類型（注射,口服,其他）,應用（腫瘤學,炎症性疾病,丙型肝炎,多發性硬化症,其他）,用途（零售,醫院,其他）2022-2028區域預測

Global Specialty Generics Market Size study, by Type (Injectables, Oral Drugs, Others), By Application (Oncology, Inflammatory Conditions, Hepatitis C, Multiple Sclerosis, Others) by End-use (, Retail, Hospital, Others) and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球特種仿製藥市場價值約為 672 億美元，預計在 2022-2028 年的預測期內將以超過 9.20% 的健康增長率增長。

當一種特殊藥物的專利到期時，它會被一種仿製藥取代。這些藥物用於治療慢性或複雜的醫學問題，如癌症、自身免疫性疾病、癲癇和艾滋病毒。治療丙型肝炎等複雜慢性疾病的特殊仿製藥的接受和廣泛採用是市場的關鍵驅動力。根據世界衛生組織（WHO）2022年報告，全球有超過5800萬人感染慢性丙型肝炎病毒，每年約有150萬人感染。由於免疫系統減弱和多種合併症，衰老是增加關節炎、心血管疾病和癌症等複雜慢性疾病發病率的重要危險因素。根據世界衛生組織 (WHO) 的預測，老年人口將從 2020 年的 10 億增加到 2021 年的 14 億，到 2030 年，地球上六分之一的人將超過 60 歲。到 2030 年，預計地球上六分之一的人口將超過 60 歲，隨著老齡化人口的增長，預計可實現盈利增長。大型製藥公司正在進行併購以增加其市場份額。 Biosena 於 2021 年 10 月收購了輝瑞 (Pfizer) 擁有的一家澳大利亞工廠，用於生產藥物療法。 BioCena 還於 2020 年完成了對 Hospira Adelaide 旗下輝瑞的收購。該公司是美國 200 種特種仿製藥注射劑的領先供應商。預計此類戰略活動將在預測期內推動市場增長。然而，新進入者的障礙包括品牌知名度和忠誠度、特種仿製藥的高度複雜性以及有限的盈利能力，所有這些都導致□□處方成本上升。例如，梯瓦為多發性硬化症 (MS) 患者提供了智能共付卡，以購買藥物 Copaxone。 Teva 向多發性硬化症 (MS) 患者提供智能共付卡以購買藥物 Copazone。此類活動將客戶的注意力轉移到品牌產品上，並減少了特殊通用產品的銷售。

在全球特種仿製藥市場研究中考慮的主要地區是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。北美憑藉對新藥批准的有利監管法律主導了特種仿製藥市場，佔 2021 年總收入的 36.5%。美國 FDA 已經發起了許多嘗試來改進整體批准程序。因此，美國食品藥品監督管理局 (FDA) 根據 Hatch-Waxman 法案提出了仿製藥用戶費用修正案 (GDUFA)，以加快向公眾提供安全、有效和負擔得起的仿製藥。因此，知名製造商不斷努力將特殊仿製藥推向市場。例如，2022 年 6 月，Amneal Pharmaceuticals Inc. 推出了獲美國 FDA 批准用於治療多發性硬化症和其他脊髓疾病的特殊藥物 LYVISPAH（巴氯芬）。

本報告中包含的主要市場參與者是：

梯瓦製藥工業有限公司

Viatris Inc.

諾華公司（Sand International GmbH）

棕熊製藥公司

海軍陸戰隊

博世健康公司（Valiant Pharmaceuticals International Inc.）

女士實驗室有限公司

遠籐製藥公司

Apotex 公司

Sun Pharmaceutical Industries, Inc.

本研究的目的是確定近年來各個細分市場和國家/地區的市場規模，並預測未來八年的價值。該報告旨在捕捉所研究的每個地區和國家的行業的定性和定量方面。此外，它還提供了有關關鍵方面的詳細信息，例如定義市場未來增長的驅動因素和挑戰。此外，報告還應詳細分析主要參與者的競爭格局和產品供應，以及微觀市場中可供利益相關者投資的機會。市場的詳細細分和子細分如下所述。

按類型

注射

口服藥物

雜項

按應用程序

腫瘤學

炎症性疾病

丙型肝炎

多發性硬化症

雜項

按最終用戶

零售

醫院

雜項

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

其他歐洲

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考慮的年份是：

實際年份 - 2018 年、2019 年、2020 年

2021 年基準年

預測期 - 2022 年 至 2028 年

本報告的目標受眾，全球特種仿製藥市場

主要諮詢公司和顧問

大公司、中型公司、中小企業

風險投資

增值經銷商 (VAR)

第三方知識提供者

投資銀行家

投資者

內容

第 1 章執行摘要

  • 市場快照
  • 2020-2028 年全球市場和細分市場的估計和預測
    • 專業仿製藥市場：按地區分列，2020-2028 年
    • 專業仿製藥市場：按類型劃分，2020-2028 年
    • 按應用劃分的特殊仿製藥市場：2020-2028
    • 專業仿製藥市場：按最終用途分類，2020-2028 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球市場定義和專業仿製藥的範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第 3 章專業仿製藥的全球市場動態

  • 專業通用市場影響分析（2020-2028 年）
    • 市場驅動力
      • 特殊仿製藥在復雜慢性疾病治療中的應用增加
      • 關節炎、心血管疾病和癌症等複雜慢性疾病的患病率不斷上升
    • 市場挑戰
      • 專業仿製藥的高度複雜性
    • 市場機會
      • 配方的進步

第 4 章專業仿製藥的全球市場行業分析

  • 波特的 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
    • 波特 5 力模型的未來方法（2018-2028）
  • PEST 分析
    • 政治
    • 經濟
    • 社交
    • 技術
  • 招商引資模式
  • 分析師的結論和建議
  • 熱門投資機會
  • 制勝法寶

第 5 章風險評估：COVID-19 的影響

    • 評估 COVID-19 對行業的整體影響
    • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章。全球特種仿製藥市場：按類型分類

  • 市場快照
  • 全球特殊仿製藥市場：按類型劃分的表現 - 潛力分析
  • 2018-2028 年全球特種仿製藥市場類型的估計和預測
  • 專業仿製藥市場、細分市場分析
    • 注入
    • 口服藥
    • 其他

第 7 章：全球特種仿製藥市場：按應用分類

  • 市場快照
  • 全球特種仿製藥市場：按應用進行的性能和潛力分析
  • 2018-2028 年全球特種仿製藥市場、估計和預測（按應用）
  • 全球特種仿製藥市場，細分分析
    • 腫瘤學
    • 炎症性疾病
    • 丙型肝炎
    • 多發性硬化症
    • 其他

第 8 章。全球特種仿製藥市場：按最終用途分類

  • 市場快照
  • 全球特種仿製藥市場：按最終用途分列的性能和潛力分析
  • 2018-2028 年全球特種仿製藥市場、估計和預測（按最終用途）
  • 專業仿製藥市場、細分市場分析
    • 醫院
    • 零售藥房
    • 其他

第 9 章。全球專業和仿製藥市場：區域分析

  • 專業仿製藥區域市場概況
  • 北美
    • 美國
      • 按類型劃分的估計和預測，2018-2028 年
      • 按應用劃分的估計和預測，2018-2028
      • 按最終用途分類的估計和預測，2018-2028 年
    • 加拿大
  • 歐洲特種仿製藥市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太專業仿製藥市場概覽
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲特種仿製藥市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 梯瓦製藥工業有限公司
      • 主要信息
      • 概覽
      • 財務（如果有數據）
      • 產品概覽
      • 近期發展狀況
    • Viatris Inc.
    • Novartis AG（Sandoz International GmbH）
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt
    • Bausch Health Companies Inc.（Valeant Pharmaceuticals International, Inc.）
    • Dr. Reddy's Laboratories Ltd.
    • Endo Pharmaceuticals Inc.
    • Apotex Corp.
    • Sun Pharmaceutical Industries Ltd.

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場估算
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Specialty Generics Market is valued approximately USD 67.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2022-2028. When a specialty drug's patent expires, it's replaced with a generic version. These medications are used to treat chronic or complicated medical problems such as cancer, autoimmune disorders, epilepsy, and HIV. The growing acceptance of specialty generic drugs for the treatment of complicated chronic illnesses such as hepatitis C, as well as their increasing prevalence, is a significant market driver. According to the World Health Organization (WHO) report 2022, over 58 million individuals worldwide have chronic hepatitis C virus infection, with approximately 1.5 million persons infected yearly. Due to weakened immunity and high comorbid conditions, age is a key risk factor for the increased incidence of complicated chronic illnesses such as arthritis, cardiovascular disease, and cancer. According to the World Health Organization (WHO) the elderly population climbed from 1 billion in 2020 to 1.4 billion in 2021., By 2030, one in every six persons on the planet will be 60 or older. As a result, the industry's fast rising senior population is likely to generate profitable growth prospects. To increase their market share, major pharmaceutical corporations have engaged in mergers and acquisitions. BioCena bought a Pfizer-owned Australian factory for medication therapy manufacture in October 2021. In addition, BioCena finalized the acquisition of Pfizer Inc., which is owned by Hospira Adelaide, in 2020. It is a major provider of 200 specialized generic injectables in the United States. During the projected period, such strategic activities are expected to fuel market growth. However, brand recognition and loyalty, the high complexity of specialty generic goods, and limited profitability are some of the key entry obstacles for new participants in the business, all of which contribute to growing prescription costs. Teva Pharmaceutical Industries Ltd., for example, provided smart co-pay cards to Multiple Sclerosis (MS) sufferers in order for them to purchase COPAXONE for their treatment. Cardholders who qualify receive medications at no cost. Such campaigns draw customers' attention to their branded items, reducing the sales of specialist generic products.

The key regions considered for the Global Specialty Generics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the speciality generics market due to favourable regulatory laws governing the approval of new drugs, and contributed 36.5% of total revenue in 2021. The FDA in the United States has launched many attempts to improve the overall approval process. As a result, the United States Food and Drug Administration (FDA) proposed Generic Drug User Fee Amendments (GDUFA) under the Hatch-Waxman Act to accelerate the delivery of safe and effective low-cost generic medications to the public. As a result, prominent manufacturers are always working to commercialise specialty generic medications in the market. Amneal Pharmaceuticals Inc., for example, introduced LYVISPAH (baclofen) in June 2022, a specialty medication approved by the US FDA for the treatment of multiple sclerosis and other spinal cord illnesses.

Major market player included in this report are:

Teva Pharmaceuticals Industries Ltd.

Viatris Inc.

Novartis AG (Sandoz International GmbH)

Hikma Pharmaceuticals PLC

Mallinckrodt

Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)

Dr. Reddy's Laboratories Ltd.

Endo Pharmaceuticals Inc.

Apotex Corp.

Sun Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

Injectables

Oral Drugs

Others

By Application:

Oncology

Inflammatory Conditions

Hepatitis C

Multiple Sclerosis

Others

By End-use:

Retail

Hospital

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Specialty Generics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Specialty Generics Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Specialty Generics Market, by Type, 2020-2028 (USD Billion)
    • 1.2.3. Specialty Generics Market, by Application, 2020-2028 (USD Billion)
    • 1.2.4. Specialty Generics Market, by End-use, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Specialty Generics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Specialty Generics Market Dynamics

  • 3.1. Specialty Generics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing adoption of specialty generic medicines for the treatment of complex chronic diseases.
      • 3.1.1.2. Rising prevalence of complex chronic diseases such as arthritis, cardiovascular diseases, and cancer
    • 3.1.2. Market Challenges
      • 3.1.2.1. High complex nature of specialty generic products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation

Chapter 4. Global Specialty Generics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Specialty Generics Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Specialty Generics Market by Type, Performance - Potential Analysis
  • 6.3. Global Specialty Generics Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
  • 6.4. Specialty Generics Market, Sub Segment Analysis
    • 6.4.1. Injectables
    • 6.4.2. Oral Drugs
    • 6.4.3. Others

Chapter 7. Global Specialty Generics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Specialty Generics Market by Application, Performance - Potential Analysis
  • 7.3. Global Specialty Generics Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
  • 7.4. Specialty Generics Market, Sub Segment Analysis
    • 7.4.1. Oncology
    • 7.4.2. Inflammatory Conditions
    • 7.4.3. Hepatitis C
    • 7.4.4. Multiple Sclerosis
    • 7.4.5. Others

Chapter 8. Global Specialty Generics Market, by End-use

  • 8.1. Market Snapshot
  • 8.2. Global Specialty Generics Market by End-use, Performance - Potential Analysis
  • 8.3. Global Specialty Generics Market Estimates & Forecasts by End-use 2018-2028 (USD Billion)
  • 8.4. Specialty Generics Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Others

Chapter 9. Global Specialty Generics Market, Regional Analysis

  • 9.1. Specialty Generics Market, Regional Market Snapshot
  • 9.2. North America Specialty Generics Market
    • 9.2.1. U.S. Specialty Generics Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Specialty Generics Market
  • 9.3. Europe Specialty Generics Market Snapshot
    • 9.3.1. U.K. Specialty Generics Market
    • 9.3.2. Germany Specialty Generics Market
    • 9.3.3. France Specialty Generics Market
    • 9.3.4. Spain Specialty Generics Market
    • 9.3.5. Italy Specialty Generics Market
    • 9.3.6. Rest of Europe Specialty Generics Market
  • 9.4. Asia-Pacific Specialty Generics Market Snapshot
    • 9.4.1. China Specialty Generics Market
    • 9.4.2. India Specialty Generics Market
    • 9.4.3. Japan Specialty Generics Market
    • 9.4.4. Australia Specialty Generics Market
    • 9.4.5. South Korea Specialty Generics Market
    • 9.4.6. Rest of Asia Pacific Specialty Generics Market
  • 9.5. Latin America Specialty Generics Market Snapshot
    • 9.5.1. Brazil Specialty Generics Market
    • 9.5.2. Mexico Specialty Generics Market
  • 9.6. Rest of The World Specialty Generics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Teva Pharmaceuticals Industries Ltd
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Viatris Inc.
    • 10.2.3. Novartis AG (Sandoz International GmbH)
    • 10.2.4. Hikma Pharmaceuticals PLC
    • 10.2.5. Mallinckrodt
    • 10.2.6. Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)
    • 10.2.7. Dr. Reddy's Laboratories Ltd.
    • 10.2.8. Endo Pharmaceuticals Inc.
    • 10.2.9. Apotex Corp.
    • 10.2.10. Sun Pharmaceutical Industries Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Specialty Generics Market, report scope
  • TABLE 2. Global Specialty Generics Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Specialty Generics Market estimates & forecasts by Type 2018-2028 (USD Billion)
  • TABLE 4. Global Specialty Generics Market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 5. Global Specialty Generics Market estimates & forecasts by End-use 2018-2028 (USD Billion)
  • TABLE 6. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Specialty Generics Market
  • TABLE 56. List of primary sources, used in the study of global Specialty Generics Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Specialty Generics Market, research methodology
  • FIG 2. Global Specialty Generics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Specialty Generics Market, key trends 2021
  • FIG 5. Global Specialty Generics Market, growth prospects 2022-2028
  • FIG 6. Global Specialty Generics Market, porters 5 force model
  • FIG 7. Global Specialty Generics Market, pest analysis
  • FIG 8. Global Specialty Generics Market, value chain analysis
  • FIG 9. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Specialty Generics Market, regional snapshot 2018 & 2028
  • FIG 15. North America Specialty Generics Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Specialty Generics Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific Specialty Generics Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Specialty Generics Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Specialty Generics Market, company Market share analysis (2021)